Skip to main content

Market Overview

Caladrius Biosciences (NASDAQ: CLBS)

1.62 +0.06 (3.85%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-0.29
0



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.38
0



Q4 2020
After-Hours
EPS:
REV:
-0.47
0
-0.25
-0.28
0
-12%
Q3 2020
After-Hours
EPS:
REV:
-0.47
0
-0.29
-0.29
0
0%
Q2 2020
After-Hours
EPS:
REV:
-0.49
0
-0.39
-0.32
0
17.95%
Q1 2020
After-Hours
EPS:
REV:
-0.44
0
-0.29
-0.38
0
-31.03%
Q4 2019
After-Hours
EPS:
REV:
-0.36
-0.34
-0.47
0
-38.24%
Q3 2019
After-Hours
EPS:
REV:
-0.36
-0.43
-0.47
0
-9.3%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!